142 related articles for article (PubMed ID: 35906698)
1. Chromatin accessibility landscape and active transcription factors in primary human invasive lobular and ductal breast carcinomas.
Lee S; Osmanbeyoglu HU
Breast Cancer Res; 2022 Jul; 24(1):54. PubMed ID: 35906698
[TBL] [Abstract][Full Text] [Related]
2. A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer.
Nardone A; Qiu X; Spisak S; Nagy Z; Feiglin A; Feit A; Cohen Feit G; Xie Y; Font-Tello A; Guarducci C; Hermida-Prado F; Syamala S; Lim K; Munoz Gomez M; Pun M; Cornwell M; Liu W; Ors A; Mohammed H; Cejas P; Brock JB; Freedman ML; Winer EP; Fu X; Schiff R; Long HW; Metzger Filho O; Jeselsohn R
Cancer Res; 2022 Oct; 82(20):3673-3686. PubMed ID: 35950920
[TBL] [Abstract][Full Text] [Related]
3. A Unique FOXA1-Associated Chromatin State Dictates Therapeutic Resistance in Lobular Breast Cancer.
Blawski R; Toska E
Cancer Res; 2022 Oct; 82(20):3668-3670. PubMed ID: 36245246
[TBL] [Abstract][Full Text] [Related]
4. Metastatic profiles and survival differences between infiltrating ductal carcinoma and infiltrating lobular carcinoma in invasive breast cancer.
Cavaller L; Goupille C; Arbion F; Vilde A; Body G; Ouldamer L
J Gynecol Obstet Hum Reprod; 2024 Apr; 53(4):102740. PubMed ID: 38311000
[TBL] [Abstract][Full Text] [Related]
5. Lobular-Like Features and Outcomes of Mixed Invasive Ductolobular Breast Cancer (MIDLC): Insights from 54,403 Stage I-III MIDLC Patients.
Lohani KR; Hoskin TL; Day CN; Yasir S; Boughey JC; Degnim AC
Ann Surg Oncol; 2024 Feb; 31(2):936-946. PubMed ID: 37872454
[TBL] [Abstract][Full Text] [Related]
6. Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism.
Du T; Zhu L; Levine KM; Tasdemir N; Lee AV; Vignali DAA; Houten BV; Tseng GC; Oesterreich S
Sci Rep; 2018 May; 8(1):7205. PubMed ID: 29739984
[TBL] [Abstract][Full Text] [Related]
7. Canonical Kaiso target genes define a functional signature that associates with breast cancer survival and the invasive lobular carcinoma histological type.
Sijnesael T; Richard F; Rätze MA; Koorman T; Bassey-Archibong B; Rohof C; Daniel J; Desmedt C; Derksen PW
J Pathol; 2023 Dec; 261(4):477-489. PubMed ID: 37737015
[TBL] [Abstract][Full Text] [Related]
8. Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironment.
Onkar S; Cui J; Zou J; Cardello C; Cillo AR; Uddin MR; Sagan A; Joy M; Osmanbeyoglu HU; Pogue-Geile KL; McAuliffe PF; Lucas PC; Tseng GC; Lee AV; Bruno TC; Oesterreich S; Vignali DAA
Nat Cancer; 2023 Apr; 4(4):516-534. PubMed ID: 36927792
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of invasive ductal and lobular carcinoma of the breast using MRI radiomic features: a pilot study.
Maiti S; Nayak S; Hebbar KD; Pendem S
F1000Res; 2024; 13():91. PubMed ID: 38571894
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the Clinical Behaviour of Invasive Lobular Carcinoma of the Breast Defines an Aggressive Subtype.
Makhlouf S; Atallah NM; Polotto S; Lee AHS; Green AR; Rakha EA
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791971
[TBL] [Abstract][Full Text] [Related]
11. Relevance of systems biological approach in the differential diagnosis of invasive lobular carcinoma & invasive ductal carcinoma.
Ragunath PK; Reddy BV; Abhinand PA; Ahmed SS
Bioinformation; 2012; 8(8):359-64. PubMed ID: 22570516
[TBL] [Abstract][Full Text] [Related]
12. Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1.
Sflomos G; Battista L; Aouad P; De Martino F; Scabia V; Stravodimou A; Ayyanan A; Ifticene-Treboux A; ; Bucher P; Fiche M; Ambrosini G; Brisken C
EMBO Mol Med; 2021 Mar; 13(3):e13180. PubMed ID: 33616307
[TBL] [Abstract][Full Text] [Related]
13. Recurrence in lobular carcinoma of the breast: A 14-year review.
Burns N; Bourke A
J Med Imaging Radiat Oncol; 2024 May; ():. PubMed ID: 38804125
[TBL] [Abstract][Full Text] [Related]
14. Epigenomic mapping reveals distinct B cell acute lymphoblastic leukemia chromatin architectures and regulators.
Barnett KR; Mobley RJ; Diedrich JD; Bergeron BP; Bhattarai KR; Monovich AC; Narina S; Yang W; Crews KR; Manring CS; Jabbour E; Paietta E; Litzow MR; Kornblau SM; Stock W; Inaba H; Jeha S; Pui CH; Mullighan CG; Relling MV; Pruett-Miller SM; Ryan RJH; Yang JJ; Evans WE; Savic D
Cell Genom; 2023 Dec; 3(12):100442. PubMed ID: 38116118
[TBL] [Abstract][Full Text] [Related]
15. Classification models for Invasive Ductal Carcinoma Progression, based on gene expression data-trained supervised machine learning.
Roy S; Kumar R; Mittal V; Gupta D
Sci Rep; 2020 Mar; 10(1):4113. PubMed ID: 32139710
[TBL] [Abstract][Full Text] [Related]
16. Epigenomic landscape of the human dorsal root ganglion: sex differences and transcriptional regulation of nociceptive genes.
Franco-Enzástiga Ú; Inturi NN; Natarajan K; Mwirigi JM; Mazhar K; Schlachetzki JCM; Schumacher M; Price TJ
bioRxiv; 2024 Mar; ():. PubMed ID: 38586055
[TBL] [Abstract][Full Text] [Related]
17. Appendiceal Metastasis of Breast Cancer: A Case Report and a Literature Review.
Yagyu T; Miki H; Kikawa Y; Kobayashi T; Sekimoto M
Cureus; 2024 Apr; 16(4):e57929. PubMed ID: 38725791
[TBL] [Abstract][Full Text] [Related]
18. Reporting on invasive lobular breast cancer in clinical trials: a systematic review.
Van Baelen K; Van Cauwenberge J; Maetens M; Beck G; Camden A; Chase MC; Fraser V; Freeney S; Hutcheson L; Levine JK; Lien T; Terveer R; Turner C; Senkus E; Jankowitz RC; Vandecaveye V; Floris G; Neven P; Wildiers H; Sawyer E; Vincent-Salomon A; Derksen PWB; Desmedt C
NPJ Breast Cancer; 2024 Mar; 10(1):23. PubMed ID: 38509112
[TBL] [Abstract][Full Text] [Related]
19. Clinico-morphological patterns of breast cancer including family history in a New Delhi hospital, India--a cross-sectional study.
Saxena S; Rekhi B; Bansal A; Bagga A; Chintamani ; Murthy NS
World J Surg Oncol; 2005 Oct; 3():67. PubMed ID: 16236180
[TBL] [Abstract][Full Text] [Related]
20. Proteasome inhibition reprograms chromatin landscape in breast cancer.
Kinyamu HK; Bennett BD; Ward JM; Archer T
bioRxiv; 2023 Oct; ():. PubMed ID: 37904968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
